In the current study, we used 1H Magnetic Resonance Spectroscopy (1H MRS) to quantify hepatic fat content in a relatively large number of participants with impaired glucose metabolism and without known liver disease except for different degree of hepatic steatosis, and further analyzed the quantitative association between serum FGF21 level and hepatic fat content. This evidence concerns the gene FGF21 and fatty liver disease.